Depigoid Birch 5000 Longterm Study in Adults and Adolescents

PHASE3CompletedINTERVENTIONAL
Enrollment

634

Participants

Timeline

Start Date

September 17, 2012

Primary Completion Date

July 30, 2018

Study Completion Date

July 30, 2018

Conditions
Allergic Rhinitis/Rhinoconjunctivitis +-Intermittent AsthmaSensitization Against Betula Alba (Birch) Pollen
Interventions
BIOLOGICAL

s.c. injection

3 years of therapy followed by 2 years (seasons) of treatment-free observational period

Trial Locations (2)

13057

Hautarztpraxis, Berlin

53105

Klinik und Poliklinik für Dermatologie und Allergologie der Universität, Bonn

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Leti Pharma GmbH

INDUSTRY

NCT01694836 - Depigoid Birch 5000 Longterm Study in Adults and Adolescents | Biotech Hunter | Biotech Hunter